Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome

Despite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS). A recent joint American-European Consensus Conference on ARDS formally defined the difference between ALI and ARDS based on the degree of...

Full description

Saved in:
Bibliographic Details
Published inIntensive care medicine Vol. 25; no. 9; pp. 930 - 935
Main Authors VILLAR, J, PEREZ-MENDEZ, L, KACMAREK, R. M
Format Journal Article
LanguageEnglish
Published Heidelberg Springer 01.09.1999
Berlin Springer Nature B.V
Subjects
Online AccessGet full text

Cover

Loading…
Abstract Despite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS). A recent joint American-European Consensus Conference on ARDS formally defined the difference between ALI and ARDS based on the degree of oxygenation impairment. However, this definition may not reflect the true prevalence, severity and prognosis of these syndromes. During a 22-month period, 56 consecutive mechanically ventilated patients who met the American-European Consensus definition for ARDS [arterial oxygen tension/fractional inspired oxygen (PaO(2)/FIO(2) </= 200 mmHg regardless of the level of positive end-expiratory pressure (PEEP), bilateral pulmonary infiltrates, and no evidence of left heart failure] were admitted into the intensive care units (ICU) of the Hospital del Pino, Las Palmas, Spain, and prospectively studied. The diagnosis of ALI and ARDS was made by a PEEP-FIO(2) trial, 24 h after patients met the Consensus inclusion criteria. Patients were classified as having ALI(-24 h) if the PaO(2)/FIO(2) was > 150 mmHg with PEEP = 5 cmH(2)O, and ARDS(-24 h) if the PaO(2) /FIO(2) was </= 150 mmHg with PEEP >/= 5 cmH(2)O. Overall mortality was 43 % (24 of 56). However, 24 h after inclusion, PaO(2) response to PEEP 5 cmH(2)O allowed the separation of our patients into two different groups: 31 patients met our ALI(-24 h) criteria (PaO(2)/FIO(2) > 150 mmHg) and their mortality was 22.6 %; 25 patients met our ARDS(-24 h) criteria (PaO(2)/FIO(2) </= 150 mmHg) and their mortality was 68 % (p = 0.0016). The differences in the respiratory severity index during the first 24 h of inclusion, PaO(2)/FIO(2) ratio at baseline and at 24 h, maximum plateau airway pressure, maximum level of PEEP, and number of organ system failures during the ICU stay were statistically significant. Since the use of PEEP in the American-European Consensus criteria for ARDS is not mandatory, that definition does not reflect the true severity of lung damage and outcome. Our data support the need for guidelines based on a specific method of evaluating oxygenation status before the American-European Consensus definition is adopted.
AbstractList BACKGROUNDDespite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS). A recent joint American-European Consensus Conference on ARDS formally defined the difference between ALI and ARDS based on the degree of oxygenation impairment. However, this definition may not reflect the true prevalence, severity and prognosis of these syndromes. METHODSDuring a 22-month period, 56 consecutive mechanically ventilated patients who met the American-European Consensus definition for ARDS [arterial oxygen tension/fractional inspired oxygen (PaO(2)/FIO(2) </= 200 mmHg regardless of the level of positive end-expiratory pressure (PEEP), bilateral pulmonary infiltrates, and no evidence of left heart failure] were admitted into the intensive care units (ICU) of the Hospital del Pino, Las Palmas, Spain, and prospectively studied. The diagnosis of ALI and ARDS was made by a PEEP-FIO(2) trial, 24 h after patients met the Consensus inclusion criteria. Patients were classified as having ALI(-24 h) if the PaO(2)/FIO(2) was > 150 mmHg with PEEP = 5 cmH(2)O, and ARDS(-24 h) if the PaO(2) /FIO(2) was </= 150 mmHg with PEEP >/= 5 cmH(2)O. RESULTSOverall mortality was 43 % (24 of 56). However, 24 h after inclusion, PaO(2) response to PEEP 5 cmH(2)O allowed the separation of our patients into two different groups: 31 patients met our ALI(-24 h) criteria (PaO(2)/FIO(2) > 150 mmHg) and their mortality was 22.6 %; 25 patients met our ARDS(-24 h) criteria (PaO(2)/FIO(2) </= 150 mmHg) and their mortality was 68 % (p = 0.0016). The differences in the respiratory severity index during the first 24 h of inclusion, PaO(2)/FIO(2) ratio at baseline and at 24 h, maximum plateau airway pressure, maximum level of PEEP, and number of organ system failures during the ICU stay were statistically significant. CONCLUSIONSSince the use of PEEP in the American-European Consensus criteria for ARDS is not mandatory, that definition does not reflect the true severity of lung damage and outcome. Our data support the need for guidelines based on a specific method of evaluating oxygenation status before the American-European Consensus definition is adopted.
Background: Despite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS). A recent joint American-European Consensus Conference on ARDS formally defined the difference between ALI and ARDS based on the degree of oxygenation impairment. However, this definition may not reflect the true prevalence, severity and prognosis of these syndromes. Methods: During a 22-month period, 56 consecutive mechanically ventilated patients who met the American-European Consensus definition for ARDS [arterial oxygen tension/fractional inspired oxygen (PaO2/FIO2≤ 200 mmHg regardless of the level of positive end-expiratory pressure (PEEP), bilateral pulmonary infiltrates, and no evidence of left heart failure] were admitted into the intensive care units (ICU) of the Hospital del Pino, Las Palmas, Spain, and prospectively studied. The diagnosis of ALI and ARDS was made by a PEEP-FIO2 trial, 24 h after patients met the Consensus inclusion criteria. Patients were classified as having ALI^sub -24 h^ if the PaO2/FIO2 was > 150 mmHg with PEEP = 5 cmH2O, and ARDS^sub -24 h^ if the PaO2 /FIO2 was ≤ 150 mmHg with PEEP ≥ 5 cmH2O. Results: Overall mortality was 43 % (24 of 56). However, 24 h after inclusion, PaO2 response to PEEP 5 cmH2O allowed the separation of our patients into two different groups: 31 patients met our ALI^sub -24 h^ criteria (PaO2/FIO2 > 150 mmHg) and their mortality was 22.6 %; 25 patients met our ARDS^sub -24 h^ criteria (PaO2/FIO2≤ 150 mmHg) and their mortality was 68 % (p = 0.0016). The differences in the respiratory severity index during the first 24 h of inclusion, PaO2/FIO2 ratio at baseline and at 24 h, maximum plateau airway pressure, maximum level of PEEP, and number of organ system failures during the ICU stay were statistically significant. Conclusions: Since the use of PEEP in the American-European Consensus criteria for ARDS is not mandatory, that definition does not reflect the true severity of lung damage and outcome. Our data support the need for guidelines based on a specific method of evaluating oxygenation status before the American-European Consensus definition is adopted.[PUBLICATION ABSTRACT]
Despite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress syndrome (ARDS). A recent joint American-European Consensus Conference on ARDS formally defined the difference between ALI and ARDS based on the degree of oxygenation impairment. However, this definition may not reflect the true prevalence, severity and prognosis of these syndromes. During a 22-month period, 56 consecutive mechanically ventilated patients who met the American-European Consensus definition for ARDS [arterial oxygen tension/fractional inspired oxygen (PaO(2)/FIO(2) </= 200 mmHg regardless of the level of positive end-expiratory pressure (PEEP), bilateral pulmonary infiltrates, and no evidence of left heart failure] were admitted into the intensive care units (ICU) of the Hospital del Pino, Las Palmas, Spain, and prospectively studied. The diagnosis of ALI and ARDS was made by a PEEP-FIO(2) trial, 24 h after patients met the Consensus inclusion criteria. Patients were classified as having ALI(-24 h) if the PaO(2)/FIO(2) was > 150 mmHg with PEEP = 5 cmH(2)O, and ARDS(-24 h) if the PaO(2) /FIO(2) was </= 150 mmHg with PEEP >/= 5 cmH(2)O. Overall mortality was 43 % (24 of 56). However, 24 h after inclusion, PaO(2) response to PEEP 5 cmH(2)O allowed the separation of our patients into two different groups: 31 patients met our ALI(-24 h) criteria (PaO(2)/FIO(2) > 150 mmHg) and their mortality was 22.6 %; 25 patients met our ARDS(-24 h) criteria (PaO(2)/FIO(2) </= 150 mmHg) and their mortality was 68 % (p = 0.0016). The differences in the respiratory severity index during the first 24 h of inclusion, PaO(2)/FIO(2) ratio at baseline and at 24 h, maximum plateau airway pressure, maximum level of PEEP, and number of organ system failures during the ICU stay were statistically significant. Since the use of PEEP in the American-European Consensus criteria for ARDS is not mandatory, that definition does not reflect the true severity of lung damage and outcome. Our data support the need for guidelines based on a specific method of evaluating oxygenation status before the American-European Consensus definition is adopted.
Author VILLAR, J
KACMAREK, R. M
PEREZ-MENDEZ, L
Author_xml – sequence: 1
  givenname: J
  surname: VILLAR
  fullname: VILLAR, J
  organization: Research Institute, Hospital de la Candelaria, Tenerife, Canary Islands, Spain
– sequence: 2
  givenname: L
  surname: PEREZ-MENDEZ
  fullname: PEREZ-MENDEZ, L
  organization: Department of Epidemiology, Research Institute, Hospital de la Candelaria, Tenerife, Spain
– sequence: 3
  givenname: R. M
  surname: KACMAREK
  fullname: KACMAREK, R. M
  organization: Department of Respiratory Care, Massachussetts General Hospital, Boston, United States
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=1944804$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/10501747$$D View this record in MEDLINE/PubMed
BookMark eNpd0c1rFDEYBvAgFbutHr1KEOltNF8zkznKom2h0Iueh3y80SyzyTYfhT33HzfLLtj2FML7y0Nengt0FmIAhD5S8pUSMn7LhFAuCOnJJMUbtKKCs44yLs_QinDBOjEIdo4uct40OQ49fYfOaeN0FOMKPa1rShAKtuB88MXHkHF0WJlaAC81_ME-bGraYxUsLn_hNEmQdz6pEtvE-lzaPeO8DzbFLWAbcYilIbeAKYdnPuGSKuAMj5B8OcbFWkzj79Fbp5YMH07nJfr988ev9U13d399u_5-1xku-tKJnqpBSgNOackEAcl7SxXR3PXGiVHp3hKuNdN6IFI7RrUDayk100DEQPglujrm7lJ8qJDLvPXZwLKoALHmeZjYODB6gJ9fwU2sKbS_zdPE5Mgn2TfUHZFJMee26rxLfqvSfqZkPlQzv6im-U-n0Kq3YJ_pYxcNfDkBlY1aXFLB-PzfTUJIIvg_l_-aCw
CODEN ICMED9
CitedBy_id crossref_primary_10_1016_j_medin_2024_01_013
crossref_primary_10_1097_01_CCM_0000224227_70642_4F
crossref_primary_10_1097_01_CCM_0000248907_05565_11
crossref_primary_10_1186_s40635_020_00334_y
crossref_primary_10_1016_S1579_2129_07_60140_2
crossref_primary_10_1097_00075198_200308000_00010
crossref_primary_10_1378_chest_07_2134
crossref_primary_10_1097_CCM_0b013e318186a443
crossref_primary_10_1097_00003246_200211000_00008
crossref_primary_10_1097_CCM_0b013e31821cb774
crossref_primary_10_1186_s13054_015_0949_y
crossref_primary_10_1007_s00134_003_1943_4
crossref_primary_10_1016_j_jcrc_2005_03_001
crossref_primary_10_1164_rccm_201308_1532CI
crossref_primary_10_1007_s00134_012_2803_x
crossref_primary_10_1097_01_CCM_0000155788_39101_7E
crossref_primary_10_1002_14651858_CD009098_pub3
crossref_primary_10_1016_j_jped_2013_02_023
crossref_primary_10_1097_CCM_0000000000001383
crossref_primary_10_1097_CCM_0b013e31817d20bd
crossref_primary_10_1155_2015_157408
crossref_primary_10_1378_chest_09_2415
crossref_primary_10_1016_j_ccm_2014_08_002
crossref_primary_10_1152_japplphysiol_00171_2008
crossref_primary_10_1097_01_CCM_0000248727_29055_25
crossref_primary_10_1007_s00134_009_1519_z
crossref_primary_10_1164_rccm_201609_1773CP
crossref_primary_10_1097_01_TA_0000078695_35172_79
crossref_primary_10_1378_chest_06_1976
crossref_primary_10_1007_s00134_003_2022_6
crossref_primary_10_1097_CCM_0000000000001724
crossref_primary_10_1016_j_lpm_2011_05_028
crossref_primary_10_4168_aard_2019_7_1_44
crossref_primary_10_1097_01_CCM_0000215598_84885_01
crossref_primary_10_1097_PCC_0000000000000350
crossref_primary_10_1186_s13054_016_1273_x
crossref_primary_10_1186_2110_5820_4_4
crossref_primary_10_1097_MCC_0b013e32834271fb
crossref_primary_10_1097_01_CCM_0000248877_66254_28
crossref_primary_10_1590_S1807_59322008000200013
crossref_primary_10_1007_s00101_013_2156_z
crossref_primary_10_1097_MCC_0b013e3283220df2
crossref_primary_10_1016_j_tacc_2020_05_005
crossref_primary_10_1378_chest_07_0617
crossref_primary_10_1007_s44164_021_00003_8
crossref_primary_10_2106_00004623_200411000_00002
crossref_primary_10_1007_s001340100989
crossref_primary_10_4266_kjccm_2013_28_1_10
crossref_primary_10_1097_01_ccx_0000198996_22072_4a
crossref_primary_10_4168_aard_2016_4_4_257
crossref_primary_10_1053_prrv_2000_0096
crossref_primary_10_1016_j_medine_2024_01_011
crossref_primary_10_1007_s00134_012_2682_1
crossref_primary_10_1016_j_medine_2012_10_011
crossref_primary_10_1016_j_medine_2014_11_004
crossref_primary_10_1038_srep44784
crossref_primary_10_3390_jcm11195724
crossref_primary_10_1164_rccm_2108052
crossref_primary_10_1177_175114371301400215
crossref_primary_10_1097_MD_0000000000003333
crossref_primary_10_1097_CCM_0b013e31828a4643
crossref_primary_10_1007_s00134_016_4242_6
crossref_primary_10_1016_j_bmhimx_2016_02_006
crossref_primary_10_1016_j_acci_2020_03_001
crossref_primary_10_1016_j_jpedp_2013_02_009
crossref_primary_10_1046_j_1365_2044_2003_03287_x
crossref_primary_10_1157_13111349
crossref_primary_10_1517_14728214_12_3_461
crossref_primary_10_1016_j_avsg_2013_03_011
crossref_primary_10_1097_PCC_0b013e31827456aa
crossref_primary_10_1164_ajrccm_164_2_2011093
crossref_primary_10_1164_rccm_200610_1534OC
crossref_primary_10_1227_NEU_0b013e3182672ae5
crossref_primary_10_1097_CCM_0b013e318226607a
crossref_primary_10_1053_crad_2001_0889
crossref_primary_10_1007_s00134_004_2519_7
crossref_primary_10_1164_rccm_201802_0273ED
crossref_primary_10_1007_s00134_013_3122_6
crossref_primary_10_1016_j_jcrc_2004_12_002
crossref_primary_10_1097_01_TA_0000135749_64867_06
crossref_primary_10_1007_s10405_009_0362_9
crossref_primary_10_1016_j_burns_2014_03_004
crossref_primary_10_1186_s13613_017_0327_9
crossref_primary_10_1007_s00134_003_1756_5
crossref_primary_10_1097_01_CCM_0000063475_65751_1D
crossref_primary_10_1378_chest_121_5_1602
crossref_primary_10_1097_01_aco_0000162831_41097_6b
crossref_primary_10_1097_01_CCM_0000057910_50618_EB
crossref_primary_10_1378_chest_07_2182
crossref_primary_10_1590_S0100_879X2006001100009
crossref_primary_10_1111_1440_1681_12656
crossref_primary_10_1007_s00134_011_2180_x
crossref_primary_10_1016_j_medin_2012_08_010
crossref_primary_10_4103_lungindia_lungindia_146_20
crossref_primary_10_1002_14651858_CD004477_pub2
crossref_primary_10_1016_j_ccc_2007_07_007
crossref_primary_10_1016_j_ejphar_2016_07_035
crossref_primary_10_1513_AnnalsATS_201303_052OC
crossref_primary_10_1007_s00134_003_2081_8
crossref_primary_10_1016_j_rmed_2007_05_021
crossref_primary_10_1016_S0002_9610_00_00432_3
crossref_primary_10_1378_chest_08_1741
crossref_primary_10_1097_01_ccx_0000134333_36779_bf
crossref_primary_10_1097_01_PCC_0000224993_03233_63
crossref_primary_10_1111_j_1399_6576_2009_02102_x
crossref_primary_10_1016_S0161_4754_01_97389_0
crossref_primary_10_1097_01_CCM_0000055402_68581_DC
crossref_primary_10_1136_bmjopen_2014_006812
crossref_primary_10_1016_j_bmhime_2017_09_001
crossref_primary_10_1016_j_ccm_2006_06_006
crossref_primary_10_1017_S0265021505001870
crossref_primary_10_1513_AnnalsATS_201508_560OC
crossref_primary_10_1097_CCM_0000000000000703
crossref_primary_10_1007_s12026_017_8983_2
crossref_primary_10_1097_ALN_0000000000001163
crossref_primary_10_1016_S1441_2772_23_02063_X
crossref_primary_10_1016_j_medin_2014_11_003
crossref_primary_10_1097_CCM_0000000000000671
crossref_primary_10_1007_s00134_004_2163_2
crossref_primary_10_1097_01_CCM_0000057904_62683_2B
crossref_primary_10_3349_ymj_2021_62_5_417
ContentType Journal Article
Copyright 1999 INIST-CNRS
Springer-Verlag Berlin Heidelberg 1999
Copyright_xml – notice: 1999 INIST-CNRS
– notice: Springer-Verlag Berlin Heidelberg 1999
DBID IQODW
CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
3V.
7RV
7X7
7XB
88E
8AO
8FD
8FI
8FJ
8FK
ABUWG
AFKRA
BENPR
CCPQU
FR3
FYUFA
GHDGH
K9.
M0S
M1P
M7Z
NAPCQ
P64
PQEST
PQQKQ
PQUKI
7X8
DOI 10.1007/s001340050984
DatabaseName Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
ProQuest Central (Corporate)
ProQuest Nursing and Allied Health Journals
ProQuest_Health & Medical Collection
ProQuest Central (purchase pre-March 2016)
Medical Database (Alumni Edition)
ProQuest Pharma Collection
Technology Research Database
Hospital Premium Collection
Hospital Premium Collection (Alumni Edition)
ProQuest Central (Alumni) (purchase pre-March 2016)
ProQuest Central (Alumni)
ProQuest Central
AUTh Library subscriptions: ProQuest Central
ProQuest One Community College
Engineering Research Database
Health Research Premium Collection
Health Research Premium Collection (Alumni)
ProQuest Health & Medical Complete (Alumni)
Health & Medical Collection (Alumni Edition)
PML(ProQuest Medical Library)
Biochemistry Abstracts 1
Nursing & Allied Health Premium
Biotechnology and BioEngineering Abstracts
ProQuest One Academic Eastern Edition (DO NOT USE)
ProQuest One Academic
ProQuest One Academic UKI Edition
MEDLINE - Academic
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
Technology Research Database
ProQuest One Academic Eastern Edition
ProQuest Health & Medical Complete (Alumni)
ProQuest Central (Alumni Edition)
ProQuest One Community College
ProQuest Nursing & Allied Health Source
ProQuest Hospital Collection
Health Research Premium Collection (Alumni)
ProQuest Pharma Collection
ProQuest Hospital Collection (Alumni)
Biotechnology and BioEngineering Abstracts
ProQuest Central
Nursing & Allied Health Premium
ProQuest Health & Medical Complete
Health Research Premium Collection
ProQuest Medical Library
ProQuest One Academic UKI Edition
Health and Medicine Complete (Alumni Edition)
Biochemistry Abstracts 1
Engineering Research Database
ProQuest One Academic
ProQuest Medical Library (Alumni)
ProQuest Central (Alumni)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
Technology Research Database
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: BENPR
  name: ProQuest Central
  url: https://www.proquest.com/central
  sourceTypes: Aggregation Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1432-1238
EndPage 935
ExternalDocumentID 2629217111
10_1007_s001340050984
10501747
1944804
Genre Journal Article
Feature
GeographicLocations Spain
Canary Islands
United States--US
Tenerife
GeographicLocations_xml – name: Spain
– name: Canary Islands
– name: United States--US
– name: Tenerife
GroupedDBID ---
-53
-5E
-5G
-BR
-EM
-Y2
-~C
.55
.86
.GJ
.VR
06C
06D
0R~
0VY
199
1N0
1SB
2.D
203
28-
29J
29~
2J2
2JN
2JY
2KG
2KM
2LR
2P1
2VQ
2~H
30V
36B
3V.
4.4
406
408
409
40D
40E
53G
5GY
5QI
5RE
5VS
67Z
6NX
78A
7RV
7X7
88E
8AO
8FI
8FJ
8TC
8UJ
95-
95.
95~
96X
AAAVM
AABHQ
AABYN
AAFGU
AAHNG
AAIAL
AAJKR
AAKSU
AANXM
AANZL
AAPBV
AAQQT
AARHV
AARTL
AATNV
AATVU
AAUGY
AAUYE
AAWCG
AAWTL
AAYFA
AAYIU
AAYQN
AAYTO
ABBBX
ABBXA
ABDZT
ABECU
ABFGW
ABFTV
ABHFT
ABHLI
ABHQN
ABIPD
ABJOX
ABKAS
ABKCH
ABKTR
ABLJU
ABMNI
ABMQK
ABNWP
ABOCM
ABPLI
ABPTK
ABQBU
ABSXP
ABTEG
ABTKH
ABTMW
ABULA
ABUWG
ABUWZ
ABWNU
ABXPI
ACBMV
ACBRV
ACBXY
ACBYP
ACGFO
ACGFS
ACHSB
ACHVE
ACHXU
ACIGE
ACIHN
ACIPQ
ACIWK
ACKNC
ACMDZ
ACMLO
ACOKC
ACOMO
ACPRK
ACREN
ACTTH
ACUDM
ACVWB
ACWMK
ADBBV
ADHHG
ADHIR
ADIMF
ADINQ
ADKNI
ADKPE
ADMDM
ADOXG
ADRFC
ADTPH
ADURQ
ADYFF
ADYOE
ADZKW
AEAQA
AEBTG
AEEQQ
AEFIE
AEFTE
AEGAL
AEGNC
AEJHL
AEJRE
AEKMD
AENEX
AEOHA
AEPYU
AESKC
AESTI
AETLH
AEVLU
AEVTX
AEXYK
AFAFS
AFEXP
AFFNX
AFJLC
AFKRA
AFLOW
AFNRJ
AFQWF
AFRAH
AFWTZ
AFYQB
AFZKB
AGAYW
AGDGC
AGGBP
AGGDS
AGJBK
AGKHE
AGMZJ
AGQMX
AGWIL
AGWZB
AGYKE
AHAVH
AHBYD
AHIZS
AHKAY
AHMBA
AHSBF
AHVUH
AHYZX
AIAKS
AIIXL
AILAN
AIMYW
AITGF
AJBLW
AJDOV
AJRNO
AKMHD
AKQUC
ALMA_UNASSIGNED_HOLDINGS
ALWAN
AMKLP
AMTXH
AMXSW
AMYLF
AMYQR
AOCGG
ARMRJ
AXYYD
AZFZN
B-.
BA0
BBWZM
BDATZ
BENPR
BGNMA
BKEYQ
BPHCQ
BVXVI
CAG
CCPQU
COF
CS3
CSCUP
DDRTE
DL5
DNIVK
DPUIP
DU5
EBD
EBLON
EBS
EIOEI
EJD
EMB
EMOBN
EN4
ESBYG
EX3
F5P
FEDTE
FERAY
FFXSO
FIGPU
FINBP
FNLPD
FRRFC
FSGXE
FWDCC
FYUFA
G-Y
G-Z
GGCAI
GGRSB
GJIRD
GNWQR
GQ6
GQ7
GQ8
GRRUI
GXS
H13
HF~
HG5
HG6
HMJXF
HQYDN
HRMNR
HZ~
I09
IAO
IEA
IHE
IHR
IJ-
IKXTQ
IMOTQ
INH
IOF
IQODW
ITM
IWAJR
IXC
IZIGR
IZQ
I~X
I~Z
J-C
J0Z
J5H
JBSCW
JCJTX
JZLTJ
KDC
KOV
KOW
KPH
LAS
LLZTM
LMP
M1P
M4Y
MA-
MJL
N2Q
N9A
NAPCQ
NB0
NDZJH
NPVJJ
NQJWS
NU0
O9-
O93
O9G
O9I
O9J
OAM
OVD
P19
P2P
P9S
PF0
PQQKQ
PROAC
PSQYO
PT4
PT5
Q2X
QOK
QOR
QOS
R4E
R89
R9I
RHV
RIG
RNI
ROL
RPX
RRX
RSV
RZK
S16
S1Z
S26
S27
S28
S37
S3B
SAP
SCLPG
SDE
SDH
SDM
SHX
SISQX
SJYHP
SMD
SNE
SNPRN
SNX
SOHCF
SOJ
SPISZ
SRMVM
SSLCW
SSXJD
STPWE
SV3
SZ9
SZN
T13
T16
TEORI
TSG
TSK
TSV
TT1
TUC
U2A
U9L
UG4
UKHRP
UNUBA
UOJIU
UTJUX
UZXMN
VC2
VFIZW
W23
W48
WJK
WK8
WOW
X7M
YCJ
YLTOR
Z45
Z5O
Z7R
Z7S
Z7U
Z7V
Z7W
Z7X
Z7Y
Z7Z
Z81
Z82
Z83
Z85
Z86
Z87
Z8M
Z8N
Z8O
Z8P
Z8Q
Z8S
Z8T
Z8U
Z8V
Z8W
Z8Z
Z91
ZA5
ZGI
ZMTXR
ZOVNA
~EX
AACDK
AAEOY
AAJBT
AASML
AAYZH
ABAKF
ABJNI
ACAOD
ACDTI
ACZOJ
AEFQL
AEMSY
AFBBN
AGQEE
AGRTI
AIGIU
AJOOF
ALIPV
CGR
CUY
CVF
ECM
EIF
HMCUK
HVGLF
ITC
NPM
AAYXX
CITATION
7XB
8FD
8FK
FR3
K9.
M7Z
P64
PQEST
PQUKI
7X8
ID FETCH-LOGICAL-c345t-451a688cefab8240e835d1a0b3f5cf47ab5d03bb2bb608bf21bfedd11c9604603
IEDL.DBID BENPR
ISSN 0342-4642
IngestDate Fri Oct 25 07:00:21 EDT 2024
Thu Oct 10 22:17:42 EDT 2024
Thu Sep 26 16:45:52 EDT 2024
Wed Oct 16 00:53:52 EDT 2024
Sun Oct 29 17:09:02 EDT 2023
IsPeerReviewed true
IsScholarly true
Issue 9
Keywords Human
Lung disease
Intensive care
Prognosis
Respiratory disease
Acute
Lung
Expiration
Artificial ventilation
Survival
Adult respiratory distress syndrome
Positive pressure
Risk factor
Adult
Diagnosis
Lesion
Oxygenation
Mechanical ventilation
Language English
License CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c345t-451a688cefab8240e835d1a0b3f5cf47ab5d03bb2bb608bf21bfedd11c9604603
Notes ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
PMID 10501747
PQID 992873985
PQPubID 48752
PageCount 6
ParticipantIDs proquest_miscellaneous_69276210
proquest_journals_992873985
crossref_primary_10_1007_s001340050984
pubmed_primary_10501747
pascalfrancis_primary_1944804
PublicationCentury 1900
PublicationDate 1999-09-01
PublicationDateYYYYMMDD 1999-09-01
PublicationDate_xml – month: 09
  year: 1999
  text: 1999-09-01
  day: 01
PublicationDecade 1990
PublicationPlace Heidelberg
Berlin
PublicationPlace_xml – name: Berlin
– name: Heidelberg
– name: United States
PublicationTitle Intensive care medicine
PublicationTitleAlternate Intensive Care Med
PublicationYear 1999
Publisher Springer
Springer Nature B.V
Publisher_xml – name: Springer
– name: Springer Nature B.V
References 10990128 - Intensive Care Med. 2000 Jul;26(7):1019
10501737 - Intensive Care Med. 1999 Sep;25(9):884-6
References_xml
SSID ssj0017651
Score 2.0805976
Snippet Despite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress syndrome...
Background: Despite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress...
BACKGROUNDDespite intensive research, there are no universally accepted clinical definitions for acute lung injury (ALI) or the acute respiratory distress...
SourceID proquest
crossref
pubmed
pascalfrancis
SourceType Aggregation Database
Index Database
StartPage 930
SubjectTerms Adolescent
Adult
Aged
Anesthesia. Intensive care medicine. Transfusions. Cell therapy and gene therapy
Biological and medical sciences
Edema
Emergency and intensive respiratory care
Epidemiology
Female
Heart failure
Humans
Intensive care
Intensive care medicine
Male
Medical sciences
Middle Aged
Mortality
Prognosis
Research centers
Respiration, Artificial
Respiratory distress syndrome
Respiratory Distress Syndrome, Adult - diagnosis
Respiratory Distress Syndrome, Adult - mortality
Respiratory Distress Syndrome, Adult - physiopathology
Respiratory Distress Syndrome, Adult - therapy
Respiratory Function Tests - statistics & numerical data
Severity of Illness Index
Spain - epidemiology
Terminology as Topic
Treatment Outcome
Title Current definitions of acute lung injury and the acute respiratory distress syndrome do not reflect their true severity and outcome
URI https://www.ncbi.nlm.nih.gov/pubmed/10501747
https://www.proquest.com/docview/992873985
https://search.proquest.com/docview/69276210
Volume 25
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3dS8MwED_cBiKI-O2cH3kQ34pt07TNk6hMRJiIONhbSZoEJtLOrfsL_Me9tNnmHvQ5IYS75O6X3N3vAK5MlKRSaOrV9Vvor4XHdcq8kKJFjqnhgtni5MFL_DSMnkds5HJzZi6tcmETa0Otytz-kd9wjtie8pTdTr482zTKBlddB40WdEJ8KPht6Nz3X17flmGEJK77L1qaOy9CpO1INuvaOQt-opr-JI3WnNL2RMxQPqZpbPE38qw90OMu7DjoSO4aXe_Bhi72YXPgguMH8O24lojSZlw0qVikNETk80qTT7zVZFx8oAyJKBRB4OdGpqtoO1HjpniELJgMiCpJUVY4ydgPflIHFkg1nWuCPlXb1nf1cuW8QjnqQxg-9t8fnjzXY8HLacQqL2KBiNM010bIFL27RkSmAuFLaliOihSSKZ9KGUoZ-6k0YSCNVioIcsvqEvv0CNpFWegTIJpT-8dMw9yg-aWBCHEdxTUCxjgQid-F64WQs0lDpZEtSZN_a6ML52sqWM3m-Jj0cby3UEnmbtwsW56PLlwuR_Gq2PiHKHQ5n2UxD9H0B7iR40aPv7bB8LBEyem_K_dgqyFtsBlmZ9C2sj5HSFLJC2glo-TCHb8f3ETi3g
link.rule.ids 315,783,787,12068,21400,27936,27937,31731,31732,33756,33757,43322,43817,74073,74630
linkProvider ProQuest
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LSwMxEA5aQQUR31at5iDeFjebze7mJCKW-mhPFXpbkk0CFdmt7fYX-MedZNNWD3pOCGEmmfmSmfkGoWsTp5kUmgaufgv8tQi4zlgQUbDICTVcMFuc3B8kvbf4ecRGPjdn5tMqFzbRGWpVFfaP_JZzwPaUZ-xu8hnYplE2uOo7aKyjDUvDZRsYpKPle4ukieu-aEnughhwtqfYdJVzFvrEjvwki3-5pJ2JmIF0TNPW4m_c6fxPdw_teuCI7xtN76M1XR6gzb4PjR-iL8-0hJU247JJxMKVwaKY1xp_wJ3G4_IdJIhFqTDAPj8yXcXasRo3pSN4wWOAVYXLqoZJxn7vYxdWwPV0rjF4VG0b37nlqnkNUtRH6K37OHzoBb7DQlDQmNVBzIhIsqzQRsgMfLsGPKaICCU1rAA1CslUSKWMpEzCTJqISKOVIqSwnC5JSI9Rq6xKfYqw5tT-MNOoMGB8KRERrKO4BriYEJGGbXSzEHI-aYg08iVl8k9ttFHnlwpWszk8JUMYP1-oJPf3bZYvT0cbXS1H4aLY6IcodTWf5QmPwPAT2MhJo8cf22BwWOL07N-Vr9BWb9h_zV-fBi_naLuhb7C5ZheoZeXeAXBSy0t3BL8Bgqvjgg
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1LT-QwDLZgkBDSCsGywPDMAXGraJtHmxPiNeKxjBBaJG5V0iTSINTOMp1fsH98nTYzwAHOqaLIduyvsf0Z4MixLNfK0qjt38J4rSJpcx6lFD2yoE4q7puT74fi-ondPvPnQCk0CWWVM5_YOmpTl_6N_ERKxPZU5vzEhaqIh8vB6fhv5AdI-URrmKaxCEsZEzTuwdL51fDhcZ5SyEQ7i9FT3kUMUXcg3Gz76DwQYi0VSs4-BagfYzVBWbluyMXXKLSNRoM1WA0wkpx1el-HBVv9hOX7kCjfgH-Bd4kY60ZVV5ZFakdUOW0secUbTkbVC8qTqMoQBIFh5e09807MqGskITNWA2JqUtUNfuT8Yz9pkwykeZtagvHV-jF47Xb1tEGZ2l_wNLj6c3EdhXkLUUkZbyLGEyXyvLRO6RwjvUV0ZhIVa-p4iUpVmpuYap1qLeJcuzTRzhqTJKVneBEx3YReVVd2G4iV1L8307R06IppolLcx0iL4FEkKov7cDwTcjHuaDWKOYHyR230Yf-TCt6_lvhjGeP67kwlRbh9k2JuK304nK_itfG5EFXZejophEwxDCR4kK1Ojx-OwdFYWLbz7c6HsIz2V_y-Gd7twkrH5eALz_ag58W-j0il0QfBBv8D-KXpHw
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Current+definitions+of+acute+lung+injury+and+the+acute+respiratory+distress+syndrome+do+not+reflect+their+true+severity+and+outcome&rft.jtitle=Intensive+care+medicine&rft.au=Villar%2C+Jesus&rft.au=P%C3%A9rez-m%C3%A9ndez%2C+L&rft.au=Kacmarek%2C+R+M&rft.date=1999-09-01&rft.pub=Springer+Nature+B.V&rft.issn=0342-4642&rft.eissn=1432-1238&rft.volume=25&rft.issue=9&rft.spage=930&rft_id=info:doi/10.1007%2Fs001340050984&rft.externalDBID=HAS_PDF_LINK&rft.externalDocID=2629217111
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0342-4642&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0342-4642&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0342-4642&client=summon